Impact of an analytical treatment interruption on partners and family members of trial participants in Durban, South Africa: a qualitative study

ATI-inclusive HIV cure trials affect participants and their close social networks comprised of family members and intimate partners. Ethical trials are responsible for ensuring the safety of participants and other impacted groups. Family and partners were a critical source of support for trial participants, but have been underutilized in ATI-inclusive trials. Leveraging this existing support network in future ATI trials may improve safety while facilitating recruitment, willingness to discontinue ART during ATIs, prevent early ATI discontinuation, support adherence to frequent visits and sampling requirements, improving overall trial success.

Authors

Institutions

Publication Details

Journal
Frontiers in Public Health
Published
2025-12-15
DOI
https://doi.org/10.3389/fpubh.2025.1662141
Primary Topic
Ethics in Clinical Research
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Impact of an analytical treatment interruption on partners and family members of trial participants in Durban, South Africa: a qualitative study

Vanessa Pillay, Annie Miall, Karine Dubé, Maud Mthembu et al.
Frontiers in Public Health
Ethics in Clinical Research
article

Impact of an analytical treatment interruption on partners and family members of trial participants in Durban, South Africa: a qualitative study

Vanessa Pillay, Annie Miall, Karine Dubé, Maud Mthembu, Thumbi Ndung’u, Ayanda Zulu, Deborah Mindry, Makhosonke Ngcobo, Krista L. Dong, Ali Ahmed, Luyanda Maphalala, Whitney Tran, Rachel Lau, Ntombifuthi Langa
article en

Abstract

ATI-inclusive HIV cure trials affect participants and their close social networks comprised of family members and intimate partners. Ethical trials are responsible for ensuring the safety of participants and other impacted groups. Family and partners were a critical source of support for trial participants, but have been underutilized in ATI-inclusive trials. Leveraging this existing support network in future ATI trials may improve safety while facilitating recruitment, willingness to discontinue ART during ATIs, prevent early ATI discontinuation, support adherence to frequent visits and sampling requirements, improving overall trial success.

Frontiers in Public HealthVol. 13
University of Zululand (ZA), Harvard University (US), Centre for the AIDS Programme of Research in South Africa (ZA), Edendale Hospital (ZA), Ragon Institute of MGH, MIT and Harvard (US), University of California San Diego (US), Massachusetts General Hospital (US), Africa Health Research Institute (ZA), Project Empower (ZA), University College London (GB)
Gilead Sciences, National Institute of Mental Health, National Institute of Allergy and Infectious Diseases
Openalex Percentile: Top 49%
Ethics in Clinical Research
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.